Infection prevention in severely myelosuppressed patients: A comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora

The American Journal of Medicine

Volumn 96, Issue 4, 1994, Pages 335-341

  Jansen, Jan ^a   Cromer, Morris ^a   Akard, Luke ^a   Black, John R ^a   Wheat, L Joseph ^a   Allen, Stephen D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; NEOMYCIN; POLYMYXIN B;

ACUTE LEUKEMIA; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZATION; RASH; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; BONE MARROW DISEASES; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTES; HUMANS; INTESTINES; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NALIDIXIC ACID; NEOMYCIN; PATIENT COMPLIANCE; POLYMYXIN B; TREATMENT OUTCOME;

EID: 0028216891     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(94)90063-9     Document Type: Article

References (41)

1. Infection in recipients of bone marrow transplants
2. Investigation of infection in immunocompromised patients
3. Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient
4. Infectious complications of bone marrow transplantation
5. From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
6. Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia
7. Controlled trials of double betalactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients
8. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia
9. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia
10. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia
11. Antimicrobial prophylaxis in acute leukemia: prospective randomized study comparing two methods of selective decontamination
12. Partial antibiotic decontamination
13. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia
14. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy
15. Effect of trimethoprimsulfa-methoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs
16. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia
17. Emergence of high-level trimethoprim resistance in fecal escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole
18. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study
19. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies
20. The effects of the intestinal microflora of selectively decontaminated patients in the severity of acute graft-versus-host disease of the gut
21. In vitro activity of BAY 09867, a new quinoline derivative, compared with those of other antimicrobial agents
22. Pharmacokinetics and tissue penetration of ciprofloxacin
23. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin
24. Infections systémiques á streptocoques mitis et sanguis II chez les enfants neutropéniques
25. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis
26. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients
27. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia
28. Options and limitations of longterm oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients
29. Management of fever in patients with cancer and treatment-induced neutropenia
30. Prophylactic vancomycin prevents bactermia by gram-positive organisms in neutropenic bone marrow transplant patients
31. Prophylaxie des infections á gram positif apres greffe de moelle
32. Phase I/II study of high dose carboplatin/VP-16 [etoposide] with marrow rescue in refractory germ cell cancer
33. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia
34. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
35. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia
36. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation
37. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
38. Prevention of bacterial infection in neutropenic patients with hematologic malignancies
39. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation
40. Role of the macrophage in the translocation of intestinal bacteria